QuidelOrtho Corporation (Nasdaq: QDEL) unites the power of Quidel Corporation and Ortho Clinical Diagnostics behind a shared mission of developing and manufacturing innovative technologies that raise the performance of diagnostic testing and create better patient outcomes across the entire healthcare continuum. Ranked among the world’s largest in vitro diagnostics (IVD) providers, QuidelOrtho is building on more than 120 years of collective experience and innovation. We combine industry-leading expertise in immunoassay and molecular testing with a global footprint in point-of-care settings, clinical labs and transfusion medicine to advance critical diagnostic solutions at scale.
Automated Testing Solutions When efficiency, standardization and accuracy are critical to your lab’s operations, then an automated testing platform that delivers full menu automation in real lab conditions can be the right solution. Tests that were once performed manually — adding not only labor time but also risk of human error — can now be fully automated. So, you can be fully confident. At the center of our automated solution is the ORTHO VISION® Swift Platform, an award-winning, industry-leading, automated pretransfusion testing system that automates over 99% of your blood bank’s workload without compromising turnaround time.